52 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2026-05-31 | Samuel Davis | IND | Regeneron Pharmaceuticals Inc. | VP - Discovery Technologies Research | $576.90 |
| 2026-05-31 | Zoran Berkovic | IND | Regeneron Pharmaceuticals Inc. | SVP - Financial Planning & Analysis | $576.90 |
| 2026-05-31 | Larry Coury | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $576.90 |
| 2026-05-31 | David Crenshaw | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $576.90 |
| 2026-05-31 | Michele Crocco | IND | Regeneron Pharmaceuticals Inc. | VP - Human Resources | $576.90 |
| 2026-05-31 | Hanne Bak | IND | Regeneron Pharmaceuticals Inc. | SVP - PreClinical Manu. & Proc. Dev. | $576.90 |
| 2026-05-31 | Aristides Economides | IND | Regeneron Pharmaceuticals Inc. | VP - Research | $576.90 |
| 2026-05-31 | Christine Enciso | IND | Regeneron Pharmaceuticals Inc. | VP - Dev Services & Op Excellence | $576.90 |
| 2026-05-31 | Dale Fanning | IND | Regeneron Pharmaceuticals Inc. | VP - Tax | $576.90 |
| 2026-05-31 | Christopher Fenimore | IND | Regeneron Pharmaceuticals Inc. | EVP - CFO | $576.90 |
| 2026-05-31 | Richard Gluckselig | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $576.90 |
| 2026-05-31 | Philip Gregory | IND | Regeneron Pharmaceuticals Inc. | SVP - Head of Cell Medicines | $576.90 |
| 2026-05-31 | Gary Herman | IND | Regeneron Pharmaceuticals Inc. | SVP - Clinical Dev. Unit Head | $576.90 |
| 2026-05-31 | Justin Holko | IND | Regeneron Pharmaceuticals Inc. | SVP - Global Oncology & Hematology CBU | $576.90 |
| 2026-05-31 | Joseph LaRosa | IND | Regeneron Pharmaceuticals Inc. | EVP - General Counsel & Secretary | $576.90 |
| 2026-05-31 | Chia-Yang Lin | IND | Regeneron Pharmaceuticals Inc. | SVP - Immuno-Oncology | $576.90 |
| 2026-05-31 | Marion McCourt | IND | Regeneron Pharmaceuticals Inc. | EVP - Commercial | $576.90 |
| 2026-05-31 | Lori Morton | IND | Regeneron Pharmaceuticals Inc. | SVP - Research | $576.90 |
| 2026-05-31 | Andrew Murphy | IND | Regeneron Pharmaceuticals Inc. | EVP - Research | $576.90 |
| 2026-05-31 | William Olson | IND | Regeneron Pharmaceuticals Inc. | SVP - Therapeutic Proteins | $576.90 |
| 2026-05-31 | Amrita Rahmani | IND | Regeneron Pharmaceuticals Inc. | VP - Corporate Strategy | $576.90 |
| 2026-05-31 | Kerry Reinertsen | IND | Regeneron Pharmaceuticals Inc. | SVP - Strategic Alliances | $576.90 |
| 2026-05-31 | John Ryan | IND | Regeneron Pharmaceuticals Inc. | VP - Global Rare Disease & CCBU | $576.90 |
| 2026-05-31 | Leonard Schleifer | IND | Regeneron Pharmaceuticals Inc. | President & CEO | $576.90 |
| 2026-05-31 | Mark Volpe | IND | Regeneron Pharmaceuticals Inc. | Senior Vice President - Tax | $576.90 |
| 2026-05-31 | Paige White | IND | Regeneron Pharmaceuticals Inc. | VP - Strategic Customer Engagement | $576.90 |
| 2026-05-31 | Brian Zambrowicz | IND | Regeneron Pharmaceuticals Inc. | EVP - Functional Genomics and Chief VG | $576.90 |
| 2026-05-31 | Ned Braunstein | IND | Regeneron Pharmaceuticals Inc. | EVP - Regulatory Affairs | $576.00 |
| 2026-05-31 | Maya Bermingham | IND | Regeneron Pharmaceuticals Inc. | SVP - Gov. Affairs & Public Policy | $576.00 |
| 2026-05-31 | Sally Paull | IND | Regeneron Pharmaceuticals Inc. | Executive VP - Human Resources | $576.00 |
| 2026-05-31 | George Fraley | IND | Regeneron Pharmaceuticals Inc. | SVP - Associate General Counsel | $345.00 |
| 2026-05-31 | Nisha Koria | IND | Regeneron Pharmaceuticals Inc. | Executive Director, Public Policy | $288.45 |
| 2026-05-31 | Timothy Landy | IND | Regeneron Pharmaceuticals Inc. | VP - Commercial | $288.45 |
| 2026-05-31 | Albert Torri | IND | Regeneron Pharmaceuticals Inc. | VP - Bioanalytical Science | $288.45 |
| 2026-05-31 | Eben DuRoss | IND | Regeneron Pharmaceuticals Inc. | Director, Govt Affairs & Public Policy | $288.45 |
| 2026-05-31 | David Glass | IND | Regeneron Pharmaceuticals Inc. | VP - Research | $288.45 |
| 2026-05-31 | Jessica Nagro | IND | Regeneron Pharmaceuticals Inc. | Director - Government Affairs | $288.45 |
| 2026-05-31 | Kimberly Greco | IND | Regeneron Pharmaceuticals Inc. | Executive Dir. of Gvt. Affairs | $288.45 |
| 2026-05-31 | Kellie Taylor | IND | Regeneron Pharmaceuticals Inc. | VP - CMC Regulatory Affairs | $288.45 |
| 2026-05-31 | Katherine Haddad | IND | Regeneron Pharmaceuticals Inc. | Sr. Dir., Gvt. Affairs & Public Policy | $288.45 |
| 2026-05-31 | Justin Pine | IND | Regeneron Pharmaceuticals Inc. | Director - Public Policy | $288.45 |
| 2026-05-31 | Ryan Crowe | IND | Regeneron Pharmaceuticals Inc. | SVP - Investor Relations | $288.45 |
| 2026-05-31 | Christopher Daly | IND | Regeneron Pharmaceuticals Inc. | VP - Oncology & Angiogenesis | $288.45 |
| 2026-05-31 | Madeleine Davidson | IND | Regeneron Pharmaceuticals Inc. | Director, Gvt. Affairs & Public Policy | $288.45 |
| 2026-05-31 | Joanna Young | IND | Regeneron Pharmaceuticals Inc. | Sr. Dr., Gvt. Affairs & Public Policy | $240.00 |
| 2026-05-31 | Jason Pitofsky | IND | Regeneron Pharmaceuticals Inc. | SVP - Controller | $225.00 |
| 2026-05-31 | Gang Chen | IND | Regeneron Pharmaceuticals Inc. | SVP - Protein Expression Sciences | $150.00 |
| 2026-05-31 | Christina Chan | IND | Regeneron Pharmaceuticals Inc. | SVP - Corporate Affairs | $115.38 |
| 2026-05-31 | Vera Mastey | IND | Regeneron Pharmaceuticals Inc. | VP - Health Econ & Outcomes Research | $115.38 |
| 2026-05-31 | Michelle LaFond | IND | Regeneron Pharmaceuticals Inc. | VP - Preclinical Manuf. & Process | $75.00 |
| 2026-05-15 | JP Morgan Chase Bank, NA | ORG | $885.00 | ||
| 2026-05-06 | Regeneron Pharmaceuticals, Inc. | ORG | $530.08 |